SEARCH

SEARCH BY CITATION

References

  • 1
    Higgins, M., Kannel, W., Garrison, R., Pinsky, J., Stokes, J. III (1988) Hazards of obesity—the Framingham experience. Acta Med Scand Suppl. 723: 2336.
  • 2
    Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H., Harris, TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282: 21312135.
  • 3
    Ridker, P. M., Hennekens, C. H., Buring, J. E., Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342: 836843.
  • 4
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 24862497.
  • 5
    National Institutes of Health/National Heart, Lung, and Blood Institute (1998) Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults—the evidence report. Obes Res. 6: (Suppl 2), 51S209S.
  • 6
    Hauptman, J., Lucas, C., Boldrin, M. N., Collins, H., Segal, KR (2000) Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med. 9: 160167.
  • 7
    Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al (2002) Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346: 393403.
  • 8
    Tuomilehto, J., Lindstrom, J., Eriksson, J. G., et al (2001) Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 344: 13431350.
  • 9
    Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., Poehlman, ET (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105: 564569.
  • 10
    Bray, GA (2001) Drug treatment of obesity. Rev Endocr Metab Disord. 2: 403418.
  • 11
    Poston, W. S. II, Foreyt, J P.. (2000) Successful management of the obese patient. Am Fam Physician 61: 36153622.
  • 12
    Astrup, A., Grunwald, G. K., Melanson, E. L., Saris, W. H., Hill, JO (2000) The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord. 24: 15451552.
  • 13
    de Lorgeril, M., Salen, P., Martin, J. L., Monjaud, I., Delaye, J., Mamelle, N. (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99: 779785.
  • 14
    Stubbs, R. J., Johnstone, A. M., O'Reilly, L. M., Barton, K., Reid, C. (1998) The effect of covertly manipulating the energy density of mixed diets on ad libitum food intake in ‘pseudo free-living’ humans. Int J Obes Relat Metab Disord. 22: 980987.
  • 15
    Weinsier, R. L., Johnston, M. H., Doleys, D. M., Bacon, JA (1982) Dietary management of obesity: evaluation of the time-energy displacement diet in terms of its efficacy and nutritional adequacy for long-term weight control. Br J Nutr. 47: 367379.
  • 16
    Morris, E. L., Bell, E. A., Roe, L. S., Rolls, BJ Portion size of food influences energy intake in adults Program and abstracts of the Annual Meeting of Professional Research Scientists in Experimental Biology, March 31 to April 4, 2001, Orlando, FL.
  • 17
    Rolls, B. J., Kim, S., Fedoroff, IC (1990) Effects of drinks sweetened with sucrose or aspartame on hunger, thirst and food intake in men. Physiol Behav. 48: 1926.
  • 18
    Ditschuneit, H. H., Flechtner-Mors, M., Johnson, T. D., Adler, G. (1999) Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr. 69: 198204.
  • 19
    Jakicic, J. M., Winters, C., Lang, W., Wing, RR (1999) Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women: a randomized trial. JAMA 282: 15541560.
  • 20
    McGuire, M. T., Wing, R. R., Klem, M. L., Seagle, H. M., Hill, JO (1998) Long-term maintenance of weight loss: do people who lose weight through various weight loss methods use different behaviors to maintain their weight? Int J Obes Relat Metab Disord. 22: 572577.
  • 21
    Klem, M. L., Wing, R. R., McGuire, M. T., Seagle, H. M., Hill, JO (1997) A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 66: 239246.
  • 22
    James, W. P., Astrup, A., Finer, N., et al (2000) Effect of sibutramine on weight maintenance after weight loss: a randomized trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 356: 21192125.
  • 23
    Wadden, T. A., Berkowitz, R. I., Sarwer, D. B., Prus-Wisniewski, R., Steinberg, C. (2001) Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med. 161: 218227.
  • 24
    Wadden, T. A., Berkowitz, R. I., Womble, L. G., et al (2005) Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 353: 21112120.
  • 25
    Davidson, M. H., Hauptman, J., DiGirolamo, M., et al (1999) Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 281: 235242.
  • 26
    Sjöström, L., Rissanen, A., Andersen, T., et al (1998) Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 352: 167172.
  • 27
    Lindgarde, F. (2000) The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study. J Intern Med. 248: 245254.
  • 28
    Hollander, P. A., Elbein, S. C., Hirsch, I. B., et al (1998) Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study. Diabetes Care 21: 12881294.
  • 29
    Rossner, S., Sjöström, L., Noack, R., Meinders, A. E., Noseda, G. (2000) Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res. 8: 4961.
  • 30
    Li, Z., Maglione, M., Tu, W., et al (2005) Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 142: 532546.